Get in Touch

Book a Consultation

We are dedicated to improving patients&#8217; lives by transforming clinical trials. We enable the capture, cleaning, and analysis of novel digital endpoints from wearable devices with our world-class experts and purpose-built cloud platform.

Our Passion Our Calling

Co-Founder & Chief Product Officer

Measures that are trusted and valued by all stakeholders are the foundation on which all other innovation in digital health must be based.

<h2>We are VivoSense</h2>
Since 2010, VivoSense has been revolutionizing clinical trials by developing and deploying digital endpoints from wearable devices. Our team of experts and our proprietary cloud platform add value at every phase of a clinical trial. From trial design to sensor selection and operationalization, data capture, cleaning, and analysis, our deep scientific knowledge and extensive clinical trial experience have been instrumental in helping clinical researchers analyze and interpret wearable sensor data, thereby enhancing patient research and care.

Our Story

default

center

VivoSense is Founded
&nbsp;
VivoSense was founded with funding from the Department of Defense Subcontract. VivoSense builds a software platform to leverage the real-world data created with the emergence of wearable sensors.  Device-agnostic software is built to ingest, clean, synchronize, analyze, and interpret wearable sensor data for research institutions.

2010

VivoSense Partners with Roche &amp; Biogen
&nbsp;
VivoSense has begun launching several projects for pharmaceutical-sponsored clinical trials, including an orphan drug trial for Rett Syndrome and sponsored projects for Roche and Biogen in Spinal Muscular Atrophy (SMA).

2014

VivoSense Awarded NIH Grant
&nbsp;
VivoSense was awarded an NIH grant to develop a software platform that uses sensors and analytics to target oncology care.

2019

VivoSense Develops Novel Digital Measures
&nbsp;
VivoSense adds novel digital endpoints to improve actigraphy measures in clinical research.  The Best 6 Minute Effort (B6ME) measure is introduced as a real-world alternative to the lab-based 6-minute walk test.

2020

VivoSense Closes Series A Funding
&nbsp;
VivoSense closes $25 Million Series A round.  Funding is needed to accelerate the development of real-world clinical measures from wearable and remote monitoring technologies and enhance the VivoSense platform for managing, cleaning, and analyzing data from wearable sensors and digital health technologies in clinical trials.

2022

VivoSense Hires CEO, Colin Bower
&nbsp;
Colin Bower hired as VivoSense CEO.  Vivosense Founder/CEO DudleyTabakin becomes Chief Product Officer. VivoSense continues mission of developing and validating real-world clinical measures from digital technologies and delivering these trusted measures as meaningful endpoints in regulated clinical trials.

2023

We are united in our purpose, committed in our passions, and guided by our values.

Our Mission

We sit on the bedrock of science. We are confident in what we know and our ability to put our knowledge to use. We will follow the evidence to the truth and let it speak for itself.

Seek the Truth Above All Else.

We know that trust is earned by a thousand acts and lost by one. We conduct ourselves honestly and transparently in all things because our mission is too important for shortcuts.

Operate with Integrity.

We honor our expertise and experience by recognizing the same in others. We strive to be the partners we want to have. We embrace opportunities to further common interests.

Collaborate to Drive Exceptional Outcomes.

We champion the urgency of our mission and take on the challenge with pride. We are undeterred by adversity, unafraid of adaptation, and unwavering in advancing our goals.

Be Brave. Lead Boldly.

We commit to seeing the person in every colleague, customer, and patient. We serve patients today because we may be patients tomorrow. We act intentionally to promote dignity and respect for all.

Remember the Person.

The VivoSense Team

Leadership

left

Colin Bower

Dudley Tabakin

Kate Lyden, PhD.

Doug McAllister

Rob Wilson

Kyle Busacker

Saurabh Ghei

Sandip Bharati

Ieuan Clay, PhD.

Liz Walsh

Board of Directors

Chris Garabedian

Marc Cikes

Lance Myers

 Learn More About a Career at VivoSense

Join Our Team

Upcoming Events & Conferences

CDISC + TMF Europe Interchange 2024

The Digital Biomarker Summit 2024

Innovations in Clinical Research: Broadening Clinical Trial Methods, Endpoints, and Goals

Joint FNIH/FDA Workshop

Events

About Us

Vivosense

Get in touch to learn more about what we can do for your trials.

Contact Us

Transform Your Trials

Book A Meeting

Schedule a consultation to explore designing and using validated digital measures in your clinical trials.

Let's Talk

Subscribe to email updates.  We're excited to deliver you valuable insights.